| negative regulation of proteolysis | GO:0045861 | 74 | 0.718 | |
| complement activation | GO:0006956 | 16 | 0.698 | Human |
| regulation of peptidase activity | GO:0052547 | 96 | 0.585 | |
| protein activation cascade | GO:0072376 | 19 | 0.479 | Human |
| angiogenesis | GO:0001525 | 201 | 0.460 | Mouse |
| protein processing | GO:0016485 | 163 | 0.456 | |
| positive regulation of activation of membrane attack complex | GO:0001970 | 2 | 0.418 | |
| amine metabolic process | GO:0009308 | 45 | 0.401 | |
| protein maturation | GO:0051604 | 176 | 0.386 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.385 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.354 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.338 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.319 | |
| immune effector process | GO:0002252 | 321 | 0.283 | Human |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.278 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.274 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.274 | |
| innate immune response | GO:0045087 | 157 | 0.268 | Human |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.264 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.263 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.257 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.245 | |
| humoral immune response | GO:0006959 | 57 | 0.244 | Human |
| mapk cascade | GO:0000165 | 281 | 0.244 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.234 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.227 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.219 | Mouse |
| ossification | GO:0001503 | 216 | 0.215 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.215 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.214 | |
| glucose metabolic process | GO:0006006 | 92 | 0.213 | |
| response to steroid hormone | GO:0048545 | 56 | 0.207 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.200 | |
| kidney development | GO:0001822 | 213 | 0.199 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.198 | Mouse |
| regulation of cell motility | GO:2000145 | 236 | 0.192 | |
| negative regulation of tooth mineralization | GO:0070171 | 1 | 0.190 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.188 | Mouse |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.183 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.180 | |
| cell adhesion | GO:0007155 | 329 | 0.178 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.177 | |
| response to peptide | GO:1901652 | 136 | 0.177 | |
| oxidation reduction process | GO:0055114 | 342 | 0.166 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.164 | Mouse |
| cellular amine metabolic process | GO:0044106 | 44 | 0.163 | |
| endothelium development | GO:0003158 | 45 | 0.160 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.159 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.157 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.156 | Mouse |
| positive regulation of protein kinase b signaling | GO:0051897 | 32 | 0.154 | |
| regulation of defense response | GO:0031347 | 233 | 0.154 | Human |
| triglyceride metabolic process | GO:0006641 | 51 | 0.150 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.149 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.144 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.143 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.142 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.141 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.141 | Mouse |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.140 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.139 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.132 | Mouse |
| chondroitin sulfate proteoglycan metabolic process | GO:0050654 | 20 | 0.129 | |
| cellular response to peptide | GO:1901653 | 92 | 0.127 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.126 | |
| glucose homeostasis | GO:0042593 | 128 | 0.125 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.125 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.124 | |
| regulation of cell migration | GO:0030334 | 219 | 0.121 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.119 | |
| response to interferon gamma | GO:0034341 | 34 | 0.118 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.117 | Mouse |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.117 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.116 | |
| regulation of tooth mineralization | GO:0070170 | 2 | 0.114 | |
| positive regulation of protein kinase c activity | GO:1900020 | 1 | 0.113 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.112 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.112 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.110 | |
| astrocyte activation | GO:0048143 | 2 | 0.109 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.108 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.108 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.106 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.106 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.103 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.100 | |
| ovarian follicle rupture | GO:0001543 | 2 | 0.100 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.098 | |
| hexose metabolic process | GO:0019318 | 98 | 0.098 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.098 | |
| inflammatory response | GO:0006954 | 244 | 0.097 | Human |
| regulation of protein processing | GO:0070613 | 96 | 0.097 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.096 | |
| peptide cross linking | GO:0018149 | 10 | 0.094 | |
| negative regulation of odontogenesis | GO:0042483 | 3 | 0.094 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.094 | |
| blood circulation | GO:0008015 | 195 | 0.093 | Mouse |
| lipid biosynthetic process | GO:0008610 | 179 | 0.093 | |
| response to peptide hormone | GO:0043434 | 127 | 0.091 | |
| chemotaxis | GO:0006935 | 247 | 0.091 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.089 | |
| gluconeogenesis | GO:0006094 | 39 | 0.089 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.088 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.088 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.086 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.086 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.085 | |
| lung development | GO:0030324 | 164 | 0.085 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.085 | |
| endocrine process | GO:0050886 | 39 | 0.083 | Mouse |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.082 | |
| cytokine production | GO:0001816 | 319 | 0.082 | Mouse |
| regulation of hormone levels | GO:0010817 | 211 | 0.082 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.081 | Mouse |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.080 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.080 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.079 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.079 | Mouse |
| regulation of kinase activity | GO:0043549 | 249 | 0.079 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.078 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.078 | Human |
| gland development | GO:0048732 | 330 | 0.078 | Mouse |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.076 | |
| negative regulation of cellular carbohydrate metabolic process | GO:0010677 | 19 | 0.073 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.072 | |
| camera type eye development | GO:0043010 | 266 | 0.072 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.072 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.072 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.070 | |
| response to insulin | GO:0032868 | 100 | 0.070 | |
| regulation of cell growth | GO:0001558 | 91 | 0.070 | |
| positive regulation of neutrophil migration | GO:1902624 | 12 | 0.070 | |
| terpenoid metabolic process | GO:0006721 | 25 | 0.069 | |
| female sex differentiation | GO:0046660 | 84 | 0.069 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.069 | |
| muscle tissue development | GO:0060537 | 308 | 0.068 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.067 | |
| chondroitin sulfate metabolic process | GO:0030204 | 17 | 0.066 | |
| urogenital system development | GO:0001655 | 261 | 0.066 | Mouse |
| mucopolysaccharide metabolic process | GO:1903510 | 25 | 0.066 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.065 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.065 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.065 | |
| positive regulation of peptidyl serine phosphorylation | GO:0033138 | 25 | 0.064 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.064 | |
| lateral line system development | GO:0048925 | 1 | 0.063 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.063 | |
| renal system development | GO:0072001 | 225 | 0.063 | |
| response to growth factor | GO:0070848 | 198 | 0.062 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.062 | |
| response to inorganic substance | GO:0010035 | 96 | 0.062 | |
| entry into cell of other organism involved in symbiotic interaction | GO:0051806 | 15 | 0.062 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.061 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.061 | |
| glial cell differentiation | GO:0010001 | 131 | 0.059 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.059 | |
| response to oxidative stress | GO:0006979 | 123 | 0.058 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.058 | |
| respiratory tube development | GO:0030323 | 167 | 0.057 | |
| response to acid chemical | GO:0001101 | 111 | 0.057 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.056 | |
| multicellular organism growth | GO:0035264 | 161 | 0.056 | |
| respiratory system development | GO:0060541 | 190 | 0.056 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.056 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.055 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.055 | |
| endothelial cell development | GO:0001885 | 20 | 0.054 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.054 | |
| epidermis development | GO:0008544 | 187 | 0.054 | |
| circulatory system process | GO:0003013 | 197 | 0.053 | Mouse |
| nephron development | GO:0072006 | 109 | 0.053 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.052 | |
| skin development | GO:0043588 | 220 | 0.052 | |
| adaptive immune response | GO:0002250 | 155 | 0.052 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.052 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.052 | |
| wound healing | GO:0042060 | 157 | 0.051 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.050 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.050 | |
| hexose transport | GO:0008645 | 56 | 0.049 | |
| proteoglycan metabolic process | GO:0006029 | 38 | 0.049 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.049 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.049 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.048 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.047 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.047 | |
| epithelial cell development | GO:0002064 | 159 | 0.047 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.047 | |
| fat cell differentiation | GO:0045444 | 160 | 0.047 | |
| kidney epithelium development | GO:0072073 | 121 | 0.046 | |
| response to corticosteroid | GO:0031960 | 20 | 0.046 | |
| response to osmotic stress | GO:0006970 | 21 | 0.045 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.045 | |
| regulation of gluconeogenesis | GO:0006111 | 30 | 0.045 | |
| response to monosaccharide | GO:0034284 | 67 | 0.044 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.044 | Mouse |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.044 | |
| sensory system development | GO:0048880 | 3 | 0.044 | |
| connective tissue development | GO:0061448 | 179 | 0.043 | |
| glycosaminoglycan metabolic process | GO:0030203 | 34 | 0.043 | |
| activation of immune response | GO:0002253 | 138 | 0.043 | Human |
| cell chemotaxis | GO:0060326 | 81 | 0.043 | |
| diterpenoid metabolic process | GO:0016101 | 24 | 0.043 | |
| cell cell adhesion | GO:0098609 | 41 | 0.042 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.042 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.042 | |
| positive regulation of glucose transport | GO:0010828 | 16 | 0.042 | |
| regulation of cellular response to insulin stimulus | GO:1900076 | 30 | 0.041 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.041 | |
| gliogenesis | GO:0042063 | 141 | 0.041 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.040 | |
| activation of nf kappab inducing kinase activity | GO:0007250 | 4 | 0.040 | |
| positive regulation of growth | GO:0045927 | 104 | 0.040 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.040 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.040 | |
| angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | GO:0001998 | 3 | 0.040 | |
| peptide cross linking via chondroitin 4 sulfate glycosaminoglycan | GO:0019800 | 8 | 0.039 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.039 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.038 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.038 | |
| spermatogenesis | GO:0007283 | 284 | 0.038 | |
| defense response to other organism | GO:0098542 | 197 | 0.038 | |
| female gonad development | GO:0008585 | 71 | 0.037 | |
| positive regulation of protein activation cascade | GO:2000259 | 2 | 0.037 | |
| regulation of secretion | GO:0051046 | 274 | 0.036 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.036 | |
| entry into other organism involved in symbiotic interaction | GO:0051828 | 15 | 0.036 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.036 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.035 | Mouse |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.035 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.035 | |
| hormone metabolic process | GO:0042445 | 86 | 0.035 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.035 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.035 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.035 | |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.034 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.034 | |
| regulation of complement activation | GO:0030449 | 7 | 0.034 | Human |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.034 | |
| response to alcohol | GO:0097305 | 48 | 0.034 | |
| response to nutrient levels | GO:0031667 | 109 | 0.034 | |
| neuron death | GO:0070997 | 154 | 0.034 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.033 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.033 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.033 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.033 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.033 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.033 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.033 | |
| ovulation cycle | GO:0042698 | 59 | 0.033 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.032 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.032 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.032 | Human |
| astrocyte differentiation | GO:0048708 | 43 | 0.032 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.032 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.032 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.031 | |
| cartilage development | GO:0051216 | 140 | 0.031 | |
| extracellular structure organization | GO:0043062 | 148 | 0.031 | Mouse |
| renal system process | GO:0003014 | 48 | 0.030 | Mouse |
| nephron epithelium development | GO:0072009 | 92 | 0.030 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.030 | |
| entry into host | GO:0044409 | 15 | 0.030 | |
| monosaccharide transport | GO:0015749 | 58 | 0.029 | |
| regulation of protein stability | GO:0031647 | 52 | 0.029 | |
| negative regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000584 | 2 | 0.029 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.029 | |
| glucose transport | GO:0015758 | 56 | 0.028 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.028 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.028 | |
| response to radiation | GO:0009314 | 165 | 0.028 | |
| negative regulation of carbohydrate metabolic process | GO:0045912 | 19 | 0.028 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.028 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.028 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.028 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.028 | |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 | 0.027 | |
| tooth mineralization | GO:0034505 | 9 | 0.027 | |
| cellular response to steroid hormone stimulus | GO:0071383 | 33 | 0.027 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.027 | Mouse |
| regulation of response to wounding | GO:1903034 | 189 | 0.027 | Human |
| macromolecule catabolic process | GO:0009057 | 281 | 0.027 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.027 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.027 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.026 | Mouse |
| leukocyte tethering or rolling | GO:0050901 | 3 | 0.026 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.026 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.026 | Mouse |
| cellular protein catabolic process | GO:0044257 | 155 | 0.026 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.026 | |
| response to metal ion | GO:0010038 | 47 | 0.026 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.026 | |
| cell growth | GO:0016049 | 130 | 0.025 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.025 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.025 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.025 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.025 | |
| neutrophil migration | GO:1990266 | 37 | 0.025 | |
| protein glycosylation | GO:0006486 | 55 | 0.025 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.025 | |
| nephron tubule development | GO:0072080 | 84 | 0.025 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.024 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.024 | |
| negative regulation of gluconeogenesis | GO:0045721 | 9 | 0.024 | |
| regulation of glucose transport | GO:0010827 | 32 | 0.024 | |
| metanephric glomerular visceral epithelial cell development | GO:0072249 | 2 | 0.024 | |
| adiponectin secretion | GO:0070162 | 2 | 0.024 | |
| skin morphogenesis | GO:0043589 | 38 | 0.024 | |
| entry into host cell | GO:0030260 | 15 | 0.024 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.024 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.024 | |
| regulation of platelet derived growth factor receptor alpha signaling pathway | GO:2000583 | 2 | 0.024 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.024 | |
| transmembrane transport | GO:0055085 | 412 | 0.024 | |
| heart morphogenesis | GO:0003007 | 178 | 0.023 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.023 | |
| hormone secretion | GO:0046879 | 128 | 0.023 | |
| carbohydrate transport | GO:0008643 | 62 | 0.023 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.023 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.023 | |
| cellular homeostasis | GO:0019725 | 240 | 0.023 | |
| glycosylation | GO:0070085 | 62 | 0.023 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.023 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.023 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.022 | |
| regulation of tube size | GO:0035150 | 57 | 0.022 | Mouse |
| regulation of cell size | GO:0008361 | 72 | 0.022 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.022 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.022 | |
| regulation of protein activation cascade | GO:2000257 | 7 | 0.022 | Human |
| aminoglycan metabolic process | GO:0006022 | 34 | 0.022 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.022 | Mouse |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.022 | |
| phagocytosis | GO:0006909 | 66 | 0.022 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.021 | |
| male gamete generation | GO:0048232 | 285 | 0.021 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.021 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.021 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.021 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.021 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.021 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.021 | Human |
| regulation of secretion by cell | GO:1903530 | 249 | 0.021 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.020 | |
| interleukin 27 mediated signaling pathway | GO:0070106 | 1 | 0.020 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 36 | 0.020 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.020 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.020 | |
| regulation of neutrophil chemotaxis | GO:0090022 | 14 | 0.020 | |
| metanephric glomerular epithelium development | GO:0072244 | 3 | 0.019 | |
| nuclear import | GO:0051170 | 95 | 0.019 | |
| cerebellum development | GO:0021549 | 77 | 0.019 | |
| movement in host environment | GO:0052126 | 15 | 0.019 | |
| cellular response to glucocorticoid stimulus | GO:0071385 | 13 | 0.019 | |
| mitochondrion organization | GO:0007005 | 134 | 0.019 | |
| epithelium migration | GO:0090132 | 63 | 0.019 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.019 | |
| regulation of neuron death | GO:1901214 | 134 | 0.019 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.018 | |
| stem cell differentiation | GO:0048863 | 268 | 0.018 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.018 | |
| epithelial cell migration | GO:0010631 | 63 | 0.018 | |
| lipid catabolic process | GO:0016042 | 69 | 0.018 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.018 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.018 | |
| complement activation lectin pathway | GO:0001867 | 5 | 0.018 | Human |
| peptide secretion | GO:0002790 | 114 | 0.018 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.018 | |
| movement in environment of other organism involved in symbiotic interaction | GO:0052192 | 15 | 0.018 | |
| positive regulation of complement activation | GO:0045917 | 2 | 0.018 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.018 | |
| renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure | GO:0003072 | 5 | 0.018 | Mouse |
| tissue homeostasis | GO:0001894 | 115 | 0.018 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.017 | |
| metencephalon development | GO:0022037 | 89 | 0.017 | |
| negative regulation of viral entry into host cell | GO:0046597 | 10 | 0.017 | |
| regulation of transmission of nerve impulse | GO:0051969 | 1 | 0.017 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.017 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.017 | |
| hindbrain morphogenesis | GO:0021575 | 46 | 0.017 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.017 | |
| limb development | GO:0060173 | 166 | 0.017 | |
| protein localization to organelle | GO:0033365 | 185 | 0.017 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.017 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.017 | |
| response to purine containing compound | GO:0014074 | 28 | 0.017 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.017 | |
| mineralocorticoid biosynthetic process | GO:0006705 | 1 | 0.017 | |
| ear development | GO:0043583 | 200 | 0.017 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.017 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.016 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.016 | |
| regulation of metanephric mesenchymal cell migration | GO:2000589 | 2 | 0.016 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.016 | |
| sterol metabolic process | GO:0016125 | 58 | 0.016 | |
| positive regulation of glucose import | GO:0046326 | 14 | 0.016 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.016 | |
| response to nutrient | GO:0007584 | 12 | 0.016 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.016 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.016 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.016 | |
| skeletal system development | GO:0001501 | 356 | 0.016 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.016 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.016 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.016 | |
| odontogenesis | GO:0042476 | 78 | 0.016 | |
| interleukin 8 production | GO:0032637 | 4 | 0.016 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.016 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.016 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.016 | |
| defense response to virus | GO:0051607 | 68 | 0.016 | |
| immunoglobulin production | GO:0002377 | 73 | 0.015 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.015 | |
| establishment of tissue polarity | GO:0007164 | 28 | 0.015 | |
| lipid modification | GO:0030258 | 65 | 0.015 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.015 | |
| transition metal ion transport | GO:0000041 | 38 | 0.015 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.015 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.015 | |
| negative regulation of biomineral tissue development | GO:0070168 | 11 | 0.015 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.015 | |
| response to glucocorticoid | GO:0051384 | 20 | 0.015 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.015 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.015 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.015 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.015 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.015 | |
| cellular response to lipid | GO:0071396 | 145 | 0.015 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.015 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.015 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.015 | |
| metanephric glomerular epithelial cell development | GO:0072313 | 2 | 0.015 | |
| regulation of carbohydrate biosynthetic process | GO:0043255 | 40 | 0.015 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.015 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.015 | |
| neuromuscular process | GO:0050905 | 99 | 0.015 | |
| tissue migration | GO:0090130 | 68 | 0.015 | |
| iron ion homeostasis | GO:0055072 | 36 | 0.015 | |
| neutrophil chemotaxis | GO:0030593 | 36 | 0.015 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.014 | |
| import into cell | GO:0098657 | 8 | 0.014 | |
| peptide transport | GO:0015833 | 133 | 0.014 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.014 | |
| leukocyte migration | GO:0050900 | 124 | 0.014 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.014 | |
| regulation of fatty acid biosynthetic process | GO:0042304 | 12 | 0.014 | |
| lipid oxidation | GO:0034440 | 29 | 0.014 | |
| renal tubule development | GO:0061326 | 87 | 0.014 | |
| neuron projection extension | GO:1990138 | 64 | 0.014 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.014 | |
| negative regulation of response to oxidative stress | GO:1902883 | 10 | 0.014 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.014 | |
| positive regulation of granulocyte chemotaxis | GO:0071624 | 12 | 0.014 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.014 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.014 | |
| acute inflammatory response | GO:0002526 | 41 | 0.014 | Human |
| neural tube formation | GO:0001841 | 108 | 0.014 | |
| regulation of viral entry into host cell | GO:0046596 | 12 | 0.014 | |
| axonogenesis | GO:0007409 | 274 | 0.014 | |
| regionalization | GO:0003002 | 337 | 0.013 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 23 | 0.013 | |
| regulation of protein localization | GO:0032880 | 231 | 0.013 | |
| limb morphogenesis | GO:0035108 | 149 | 0.013 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.013 | |
| positive regulation of camp dependent protein kinase activity | GO:2000481 | 3 | 0.013 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.013 | |
| hair cycle | GO:0042633 | 90 | 0.013 | |
| astrocyte development | GO:0014002 | 12 | 0.013 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.013 | |
| metanephric glomerular epithelial cell differentiation | GO:0072312 | 2 | 0.013 | |
| positive regulation of epithelial cell differentiation involved in kidney development | GO:2000698 | 2 | 0.013 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.013 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.013 | |
| interleukin 12 secretion | GO:0072610 | 3 | 0.013 | |